-
Research and development daily Novartic's rare disease drug Branaplam has been awarded the title of orphan drug by the FDA
Time of Update: 2020-10-29
2020.10.23 Research and Development NEWS FDA Approves Redsiway Treatment COVID-19; Takeda's "Aitibant" Listing Application To Be Included in Priority Review; Priut Pharmaceuticals Sulphur Teb Taling 4 generic listing applications were accepted; "cancer environmental immunotherapy" targeting TGF-β or a new dawn against cancer; Henri PD-1 joint Apatini III clinical approval...
-
East Sunshine drug impact 6 billion insulin varieties Sanofi 60% of the market is in a hurry
Time of Update: 2020-10-28
Pharmaceutical network October 19 days ago, CDE official website shows that Yichang Dong Sunshine Changjiang Pharmaceuticals insulin insulin insulin injection application was accepted. 2019, sales of
-
Three domestic cell therapy companies have IPOs, CAR-T in China from the full commercialization of how far
Time of Update: 2020-09-27
So far in 2020, Fosun Kate and Pharmaceuticals have applied for NDA and been accepted; Legendary Bio, Yongtai Bio and Pharmaceutical Ming Juno have applied for listing, including Yongtai Bio and Legendary Bio have successfully landed in Hong Kong and NASDAQ, respectively; and the FDA has once again approved the listing of a third CAR-T cell therapy product via fast track.
-
Claims that tea long-term drinking fat-lowering pressure online shop false propaganda was sentenced to three times compensation
Time of Update: 2020-09-26
The Second People's Court of Dongguan City, after hearing that the online shop constituted propaganda fraud, ordered the online shop merchants to return the purchase price and pay three times the purchase price compensation to Mr. Deng.
-
341 pharmaceutical companies published in income rankings (with list
Time of Update: 2020-09-22
Among them, the most outstanding performance is to benefit from the new crown outbreak of the device enterprises Meirui Medical, known in the industry as the innovative drug "water seller" CRO company drug Mingkangde and vaccine enterprises Zhifei Bio three enterprises last year on the basis of net profit of more than 1 billion, another increase of more than 30%.
-
The selection principle of fully automatic electronic granulome machine
Time of Update: 2020-08-26
understand how the fully automatic granulome machine works, it is necessary to carry out correct scientific operation of the equipment in order to ensure the stable operation of production.
-
"Pharmaceutical Headline Jun" is on the verge of being approved for the global mRNA pharmaceutical panorama
Time of Update: 2020-08-22
(Click on the title to obtain the original text) "Pharmaceutical first time" Beda Pharmaceuticals ALK inhibitor NSCLC Phase III clinical reached the main endpoint of Beda Pharmaceutical Holdings subsidiary Xcovery Holdings at the World Lung Cancer Congress released its next generation of ALK inhibitor enchaine hydrochloride and the same drug Pfizer Xalkori comparison of the International Multi-Center Phase 3 clinical study results.
-
Research Report on the Development of China's Dietary Nutritional Supplements Industry (2020
Time of Update: 2020-08-13
(Source: Shandong Nutrition And Health Food Industry Association) original title: Research Report "China Dietary Nutritional Supplement Industry Development Report (2020)" China's Dietary Nutrition
-
Fosun Pharma's new coronavirus mRNA vaccine phase I clinical trial approved
Time of Update: 2020-07-31
According to the announcement, Fosun Pharmaceutical Industry in March 2020 was authorized by BioNTech SE ("BioNTech" in Germany) to develop and commercialize vaccine products based on its proprietary mRNA technology platform in the region (i.e., Chinese mainland and Hong Kong, Macao and Taiwan, the same below), for the vaccine products for new coronaviruses, with BioNTech as the right person in the region.
-
Ten provincial union artificial crystal collection officially opened, the purchase volume of 169,000 pieces
Time of Update: 2020-07-29
Pharmaceutical network industry dynamics" has been, medical supplies inflated prices, excessive use and other issues troubled the masses, medical supplies chaos urgently need to be treated And to pro
-
The "stop" tide is coming? Multi-province text ingons to regulate the market harvest
Time of Update: 2020-07-23
The Medical Insurance Bureau issued a document regulating local volume procurement On July 7, , Hebei Health Insurance Bureau issued a Notice on Further Strengthening the Management of Centralized Pro
-
The Fda re-issued a letter - strengthen the mandatory industry standard management of medical devices
Time of Update: 2020-07-22
Text On July 9, the State Drug Administration issued a notice on matters related to further strengthening the management of mandatory industry standards for medical devices, and detailed the legal
-
In 2020, the pharmaceutical industry salary rate announced, do you raise wages
Time of Update: 2020-07-17
"Pharmaceutical Network Industry Dynamics" it is understood that in the first half of 2020, in the face of the sudden outbreak, many industries have been hit to varying degrees, but there are some in
-
The 6th Adamu monotonica biosimilar! Mylan/Concord Kirin Hulio has been approved by the U.S. FDA and will be available in 2023
Time of Update: 2020-07-17
July 11, 2020 // Mylan and partner Fujifilm Kyowa Kirin have jointly announced that the U.S Food and Drug Administration (FDA) has approved Hulio, amumuab-fkjp, a superweight product from AbbVie :: ad
-
One of America's 'most promising' HIV vaccine clinical trials fails
Time of Update: 2020-07-07
According to the Science Times, on September 18th a disastrous test for the AIDS vaccine was announced as a failure of a clinical trial of one of the most promising AIDS vaccines In 2004, a team of
